Connecting you to content on EBSCOhost

Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 10

Results: 6

1

Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon γ: its role in the elicitation of an effective antitumor immune response.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 563, doi. 10.1007/s002620000151

By:

Jyothi, M. Divya;
Khar, Ashok

Publication type:

Article

2

Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 530, doi. 10.1007/s002620000150

By:

Orditura, Michele;
Romano, Ciro;
De Vita, Ferdinando;
Galizia, Gennaro;
Lieto, Eva;
Infusino, Stefania;
De Cataldis, Giuseppe;
Catalano, Giuseppe

Publication type:

Article

3

Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 544, doi. 10.1007/s002620000149

By:

Piemonti, Lorenzo;
Monti, Paolo;
Zerbi, Alessandro;
Balzano, Gianpaolo;
Allavena, Paola;
Di Carlo, Valerio

Publication type:

Article

4

Targeting of cancer cells with monoclonal antibodies specific for C3b(i).

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 551, doi. 10.1007/s002620000140

By:

Sokoloff, Mitchell H.;
Nardin, Alessandra;
Solga, Michael D.;
Lindorfer, Margaret A.;
Sutherland, William M.;
Bankovich, Alexander J.;
Zhau, Haiyen E.;
Chung, Leland W. K.;
Taylor, Ronald P.

Publication type:

Article

5

Granulocyte/macrophage-colony-stimulating factor augments lymphokine-activated killer activity from lymphocytes via macrophages in lung cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 537, doi. 10.1007/s002620000144

By:

Takahashi, Keiji;
Saito, Seiya;
Kamamura, Yoshitaka;
Katakawa, Masatomo;
Monden, Yasumasa

Publication type:

Article

6

The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines.

Published in:

Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 517, doi. 10.1007/s002620000145

By:

Arlen, Philip;
Kwong-Yok Tsang;
Marshall, John L.;
Alice Chen;
Steinberg, Seth M.;
Poole, Diane;
Hand, Patricia Horan;
Schlom, Jeffrey;
Hamilton, J. Michael

Publication type:

Article